FDA Considering Further Steps to Boost Generics Competition

Generic Line
FDA Commissioner Scott Gottlieb expanded on his drug competition action plan at a day-long agency meeting on generic competition. To make the process more transparent, the agency is considering publicizing when it grants permission for brand-name companies to sell product samples of REMS-covered drugs to developers of generics.

To View This Article:


Subscribe To Generic Line